This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Scientific publications
Scientific articles authored by Novo Nordisk
The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.
| Journal | Author![]() |
Year | |
| Journal of Medical Genetics Evidence of an association between genetic variation of the coactivator PGC-1 beta and obesity |
Andersen G ; Wegner L ; Yanagisawa K ; Rose CS ; Lin J ; Glumer C ; Drivsholm T ; Borch-Johnsen K ; Jorgensen T ; Hansen T ; Spiegelman BM ; Pedersen O | 2005 | |
| British Journal of Pharmacology Effect of acute and long-term treatment with 17-beta- estradiol on the vasomotor responses in the rat aorta |
Andersen HL ; Weis JU ; Fjalland B ; Korsgaard N | 1999 | |
| Journal of Biological Chemistry 2-(Oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases |
Andersen HS ; Iversen LF ; Jeppesen CB ; Branner S ; Norris K ; Rasmussen HB ; Moller KB ; Moller NPH | 2000 | |
| Journal of Medicinal Chemistry Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B |
Andersen HS ; Olsen OH ; Iversen LF ; Sorensen ALP ; Mortensen SB ; Christensen MS ; Branner S ; Hansen TK ; Lau JF ; Jeppesen L ; Moran EJ ; Su J ; Bakir F ; Judge L ; Shahbaz M | 2002 | |
| Biochemical Journal Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling |
Andersen JN ; Elson A ; Lammers R ; Romer J ; Clausen JT ; Moller KB ; Moller NPH | 2001 | |
| Faseb Journal A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage |
Andersen JN ; Jansen PG ; Echwald SM ; Mortensen OH ; Fukada T ; Del Vecchio R ; Tonks NK ; Moller NPH | 2004 | |
| Molecular and Cellular Biology Structural and evolutionary relationships among protein tyrosine phosphatase domains |
Andersen JN ; Mortensen OH ; Peters GH ; Drake PG ; Iversen LF ; Olsen OH ; Jansen PG ; Andersen HS ; Tonks NK ; Moller NPH | 2001 | |
| Research in Microbiology Using inactivated microbial biomass as fertilizer: the fate of antibiotic resistance genes in the environment |
Andersen JT ; Schafer T ; Jorgensen PL ; Moller S | 2001 | |
| Bioorganic and Medicinal Chemistry Synthesis of novel GABA uptake inhibitors. Part 6: Preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives |
Andersen KE ; Lau J ; Lundt BF ; Petersen H ; Huusfeldt PO ; Suzdak PD ; Swedberg MDB | 2001 | |
| Journal of Medicinal Chemistry Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates |
Andersen KE ; Sorensen JL ; Huusfeldt PO ; Knutsen LJS ; Lau J ; Lundt BF ; Petersen H ; Suzdak PD ; Swedberg MDB | 1999 | |
| Journal of Medicinal Chemistry Synthesis of novel gamma-aminobutyric acid (GABA) uptake inhibitors. 5. Preparation and structure-activity studies of tricyclic analogues of known GABA uptake inhibitors |
Andersen KE ; Sorensen JL ; Lau J ; Lundt BF ; Petersen H ; Huusfeldt PO ; Suzdak PD ; Swedberg MDB | 2001 | |
| Journal of Clinical Endocrinology and Metabolism Variation of the McKusick-Kaufman gene and studies of relationships with common forms of obesity |
Andersen KL ; Echwald SM ; Larsen LH ; Hamid YH ; Glumer C ; Jorgensen T ; Borch-Johnsen K ; Andersen T ; Sorensen TIA ; Hansen T ; Pedersen O | 2005 | |
| Clinical Biochemistry A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies |
Andersen L ; Jorgensen PN ; Jensen LB ; Walsh D | 2000 | |
| Journal of Biological Chemistry Antibody-induced Enhancement of Factor VIIa Activity through Distinct Allosteric Pathways |
Andersen LM ; Andreasen PA ; Svendsen I ; Keemink J ; Ostergaard H ; Persson E | 2012 | |
| Pharmacology Biochemistry and Behavior Specific behavioral effects related to age and cerebral ischemia in rats |
Andersen MB ; Zimmer J ; Sams-Dodd F | 1999 | |
| International Journal of Mass Spectrometry Structural characterization of both the non-proteolytic and proteolytic activation pathways of coagulation Factor XIII studied by hydrogen-deuterium exchange mass spectrometry |
Andersen MD ; Faber JH | 2011 | |
| Biological Chemistry Coagulation factor XIII variants with altered thrombin activation rates |
Andersen MD ; Kjalke M ; Bang S ; Lautrup-Larsen I ; Becker P ; Andersen AS ; Olsen OH ; Stennicke HR | 2009 | |
| Cytochrome P450, Pt C Use of methylotropic yeast Pichia pastoris for expression of cytochromes P450 |
Andersen MD ; Moller BL | 2002 | |
| Pediatric Diabetes Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes |
Andersen MLM ; Vaziri-Sani F ; Delli A ; Porksen S ; Jacobssen E ; Thomsen J ; Svensson J ; Petersen JS ; Hansen L ; Lernmark A ; Mortensen HB ; Nielsen LB | 2012 | |
| Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences Determination of ragaglitazar, a novel dual acting peroxisome proliferator-activated receptor (PPAR) alpha and -gamma agonist, in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry |
Andersen MP ; Nielsen KK | 2003 | |











